Mobile-Menu
German China

Automation Strategies Integrated Automation Trends in Cell Line Development and 3D Biology

From Sartorius 3 min Reading Time

Related Vendors

Sartorius AG
DÜPERTHAL Sicherheitstechnik GmbH & Co. KG
Xylem Analytics Germany Sales GmbH & Co. KG
Bimos - eine Marke der Interstuhl Büromöbel GmbH & Co. KG

Modern biologics and cell therapy programs increasingly rely on workflows that can generate high-quality cell lines and physiologically relevant 3D models with both speed and reproducibility. Yet many laboratories continue to experience bottlenecks rooted in manual processes, heterogeneous culture formats, and fragmented instrumentation. These challenges introduce variability, constrain throughput, and make it difficult to compare results across experiments or sites.

“With Cellcelector, your team moves from single cell → validated clone → production ready line through one tightly integrated, automation driven workflow.” – Dr. Darius Wilson, Head of Product Management, Cell Selection & Retrieval, Sartorius Lab Product & Services(Source: Sartorius)
“With Cellcelector, your team moves from single cell → validated clone → production ready line through one tightly integrated, automation driven workflow.” – Dr. Darius Wilson, Head of Product Management, Cell Selection & Retrieval, Sartorius Lab Product & Services
(Source: Sartorius)

To address these limitations, research groups are adopting automation strategies that unify single cell isolation, imaging, and clonal assessment into a structured, traceable process. Rather than treating each workflow step as an isolated task, integrated approaches are emerging that allow investigators to monitor cell behavior from the initial isolation event through early productivity measurements or organoid maturation.

Evolving Needs in Cell Line Development

Related content